Mitesco (MITI) Research & Development (2011 - 2026)

Mitesco (MITI) posted quarterly Research & Development of $103533.0 for Q1 2026, up 1860.11% year-over-year from $5282.0 in Q1 2025, and up 74.02% quarter-over-quarter from $59495.0 in Q4 2025.

Mitesco (MITI) Research & Development (2011 - 2026) Analysis & Trends

Mitesco (MITI) has reported Research & Development for 7 consecutive years, with $103533.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Research & Development rose 1860.11% year-over-year to $103533.0; the TTM figure through Mar 2026 stood at $185250.0 (up 3407.19% YoY), while the FY2025 annual figure was $81717.0, changed N/A from the prior year.
  • Research & Development advanced to $103533.0 in Q1 2026 per MITI's latest filing, from $59495.0 in the prior quarter.
  • Across five years, Research & Development topped out at $103533.0 in Q1 2026 and bottomed at $1100.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 208.32 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn -
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 26.83 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 56.79 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 81.41 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn 99.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 50.38 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 45.05 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn 30.58 Mn
10 Mitesco 533,866.19 532,333.19 - 103,533.00

Historic Data

Download Data
DateValue
Mar 31, 2026 103,533.00
Dec 31, 2025 59,495.00
Sep 30, 2025 1,100.00
Jun 30, 2025 21,122.00
Mar 31, 2025 5,282.00
Sep 30, 2015 172,289.00
Jun 30, 2015 172,289.00
Mar 31, 2015 194,699.00
Dec 31, 2014 225,875.00
Sep 30, 2014 222,934.00
Jun 30, 2014 222,934.00
Mar 31, 2014 365,037.00
Dec 31, 2013 244,946.00
Sep 30, 2013 191,378.00
Jun 30, 2013 483,426.00
Mar 31, 2013 329,613.00
Dec 31, 2012 167,032.00
Sep 30, 2012 114,976.00
Jun 30, 2012 273,985.00
Mar 31, 2012 338,164.00